Loading...
OTCM
XSNX
Market cap18kUSD
Jul 18, Last price  
0.00USD
1D
0.00%
1Q
0.00%
Jan 2017
-70.00%
IPO
-99.90%
Name

NovAccess Global Inc

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
72.75%
Rev. gr., 5y
5.70%
Revenues
0k
008,0006,880000000393,5221,215,632750,5561,172,972665,0171,608,7230000
Net income
-5m
L
-1,509,068-1,400,839-3,441,940-1,289,497-4,058,952-10,634,133-2,210,603-1,117,654-1,555,194-2,522,382-1,949,887-1,320,648-242,866-498,663-3,969,4062,343,982-6,800,751-2,890,346591,187-4,769,187
CFO
-625k
L-30.86%
-1,436,630-1,049,650-1,942,278-843,416-2,695,476-2,862,327-1,347,395-1,117,818-379,240-441,718-368,368-207,068-171,972-44,844-123,966-6,542-93,190-682,333-903,489-624,636

Profile

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.
URL
https://novaccessglobal.com/
IPO date
May 01, 2002
Employees
2
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑092015‑09
Income
Revenues
Cost of revenue
154
186
Unusual Expense (Income)
NOPBT
(154)
(186)
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
(154)
(186)
Net income
(4,769)
-906.71%
591
-120.45%
Dividends
Dividend yield
Proceeds from repurchase of equity
82,499,995
221
BB yield
-3,960,998.95%
-11.14%
Debt
Debt current
2,200
1,289
Long-term debt
Deferred revenue
Other long-term liabilities
1,665
Net debt
2,178
1,225
Cash flow
Cash from operating activities
(625)
(903)
CAPEX
(4)
Cash from investing activities
Cash from financing activities
582
787
FCF
2,081
(443)
Balance
Cash
21
64
Long term investments
Excess cash
21
64
Stockholders' equity
(18,472)
(18,952)
Invested Capital
12,874
15,588
ROIC
ROCE
2.76%
5.53%
EV
Common stock shares outstanding
20,828
16,526
Price
0.10
-16.67%
0.12
-74.15%
Market cap
2,083
5.03%
1,983
-62.06%
EV
9,008
3,208
EBITDA
(154)
1,349
EV/EBITDA
2.38
Interest
1,223
1,694
Interest/NOPBT